Document Detail


Influence of mebendazole on insulin secretion from isolated rat islets.
MedLine Citation:
PMID:  3519938     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The antihelminthic drug mebendazole (MEB) has been reported to elevate circulating insulin levels in vivo. By using isolated perifused rat islets we tested the acute effects of this drug directly on the beta cell in the absence or presence of exogenous glucose. In the absence of glucose, MEB (40 micrograms/ml) caused a delayed but sustained increase in insulin output from the islet. Release induced by this concentration of MEB was not influenced by either forskolin (10 microM), a compound that increases islet cyclic AMP levels and potentiates glucose-induced secretion, or the absence of extracellular calcium. In the presence of a submaximal stimulatory glucose concentration (8 mM), release was dramatically potentiated by the further addition of 10 to 40 micrograms/ml of MEB. The potentiating effect of the drug on glucose-induced release was readily reversible and abolished by the omission of extracellular calcium or the addition of 10 mM mannoheptulose, a compound that blocks glucose phosphorylation. Despite its positive effects on hormone secretion, MEB did not affect glucose metabolism. MEB may prove useful for investigating the factors that regulate insulin secretion.
Authors:
W S Zawalich; V Diaz; S Cote
Related Documents :
395348 - Effect of diltiazem on insulin secretion. ii. experiments on perfused rat pancreas, ane...
2436458 - Influence of inorganic phosphate on glucose-induced insulin release in vitro.
6303318 - Effects of insulin secretagogues and inhibitors on phospholipid metabolism in langerhan...
6342138 - Glucose stimulation of the antilipolytic effect of insulin in humans.
19427968 - Diabetic polyneuropathy may increase the handicap related to vestibular disease.
1634898 - Effects of astrocytes, insulin and insulin-like growth factor i on the survival of moto...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  237     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1986 Jun 
Date Detail:
Created Date:  1986-07-16     Completed Date:  1986-07-16     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  826-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Glucose / metabolism,  pharmacology
Insulin / secretion*
Islets of Langerhans / drug effects*,  secretion
Male
Mebendazole / pharmacology*
Microtubules / drug effects
Rats
Rats, Inbred Strains
Grant Support
ID/Acronym/Agency:
AM00944/AM/NIADDK NIH HHS; AM34381/AM/NIADDK NIH HHS
Chemical
Reg. No./Substance:
11061-68-0/Insulin; 31431-39-7/Mebendazole; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dietary effects of trans fatty acids.
Next Document:  Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.